288 related articles for article (PubMed ID: 32994341)
1. Autoantibodies in Early Detection of Breast Cancer.
Rauf F; Anderson KS; LaBaer J
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2475-2485. PubMed ID: 32994341
[TBL] [Abstract][Full Text] [Related]
2. Autoantibodies as Potential Biomarkers in Breast Cancer.
Qiu J; Keyser B; Lin ZT; Wu T
Biosensors (Basel); 2018 Jul; 8(3):. PubMed ID: 30011807
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies as biomarkers for breast cancer diagnosis and prognosis.
Yang R; Han Y; Yi W; Long Q
Front Immunol; 2022; 13():1035402. PubMed ID: 36451832
[TBL] [Abstract][Full Text] [Related]
4. Use of autoantibodies to detect the onset of breast cancer.
Lacombe J; Mangé A; Solassol J
J Immunol Res; 2014; 2014():574981. PubMed ID: 25143958
[TBL] [Abstract][Full Text] [Related]
5. Mammography screening: A major issue in medicine.
Autier P; Boniol M
Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
[TBL] [Abstract][Full Text] [Related]
6. Evaluating Serum Markers for Hormone Receptor-Negative Breast Cancer.
Schummer M; Thorpe J; Giraldez MD; Bergan L; Tewari M; Urban N
PLoS One; 2015; 10(11):e0142911. PubMed ID: 26565788
[TBL] [Abstract][Full Text] [Related]
7. Use of autoantibodies in breast cancer screening and diagnosis.
Storr SJ; Chakrabarti J; Barnes A; Murray A; Chapman CJ; Robertson JF
Expert Rev Anticancer Ther; 2006 Aug; 6(8):1215-23. PubMed ID: 16925487
[TBL] [Abstract][Full Text] [Related]
8. Improving early detection of breast cancer in sub-Saharan Africa: why mammography may not be the way forward.
Black E; Richmond R
Global Health; 2019 Jan; 15(1):3. PubMed ID: 30621753
[TBL] [Abstract][Full Text] [Related]
9. Blueprint of quartz crystal microbalance biosensor for early detection of breast cancer through salivary autoantibodies against ATP6AP1.
Arif S; Qudsia S; Urooj S; Chaudry N; Arshad A; Andleeb S
Biosens Bioelectron; 2015 Mar; 65():62-70. PubMed ID: 25461139
[TBL] [Abstract][Full Text] [Related]
10. Autoantibody signatures: progress and perspectives for early cancer detection.
Desmetz C; Mange A; Maudelonde T; Solassol J
J Cell Mol Med; 2011 Oct; 15(10):2013-24. PubMed ID: 21651719
[TBL] [Abstract][Full Text] [Related]
11. The Advent of Salivary Breast Cancer Biomarker Detection Using Affinity Sensors.
Abrao Nemeir I; Saab J; Hleihel W; Errachid A; Jafferzic-Renault N; Zine N
Sensors (Basel); 2019 May; 19(10):. PubMed ID: 31126047
[TBL] [Abstract][Full Text] [Related]
12. Screening for cancer in low- and middle-income countries.
Sankaranarayanan R
Ann Glob Health; 2014; 80(5):412-7. PubMed ID: 25512156
[TBL] [Abstract][Full Text] [Related]
13. Autoantibodies in breast cancer.
Fernández-Madrid F; Maroun MC
Adv Clin Chem; 2014; 64():221-40. PubMed ID: 24938020
[TBL] [Abstract][Full Text] [Related]
14. Autoantibody profiles as biomarkers of breast cancer.
Tabernero MD; Lv LL; Anderson KS
Cancer Biomark; 2010; 6(5-6):247-56. PubMed ID: 20938085
[TBL] [Abstract][Full Text] [Related]
15. Responding to the challenges of breast cancer in egypt and other arab countries.
El Saghir NS
J Egypt Natl Canc Inst; 2008 Dec; 20(4):309-12. PubMed ID: 20571588
[TBL] [Abstract][Full Text] [Related]
16. Radiomics Improves Cancer Screening and Early Detection.
Gillies RJ; Schabath MB
Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2556-2567. PubMed ID: 32917666
[TBL] [Abstract][Full Text] [Related]
17. The future of blood-based biomarkers for the early detection of breast cancer.
Loke SY; Lee ASG
Eur J Cancer; 2018 Mar; 92():54-68. PubMed ID: 29413690
[TBL] [Abstract][Full Text] [Related]
18. Can serum autoantibodies be a potential early detection biomarker for breast cancer in women? A diagnostic test accuracy review and meta-analysis.
Kathrikolly T; Nair SN; Mathew A; Saxena PPU; Nair S
Syst Rev; 2022 Oct; 11(1):215. PubMed ID: 36210467
[TBL] [Abstract][Full Text] [Related]
19. A multiparametric serum marker panel as a complementary test to mammography for the diagnosis of node-negative early-stage breast cancer and DCIS in young women.
Lacombe J; Mangé A; Bougnoux AC; Prassas I; Solassol J
Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1834-42. PubMed ID: 24957886
[TBL] [Abstract][Full Text] [Related]
20. Natural and adaptive IgM antibodies in the recognition of tumor-associated antigens of breast cancer (Review).
Díaz-Zaragoza M; Hernández-Ávila R; Viedma-Rodríguez R; Arenas-Aranda D; Ostoa-Saloma P
Oncol Rep; 2015 Sep; 34(3):1106-14. PubMed ID: 26133558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
